This tag is created dynamically through created record pages
Today, FAH submitted comments to the United States Trade Representative (USTR) urging an exemption for health care goods and products from the proposed tariffs on various goods from China, which will become effective on August […]
Read More… from FAH Urges USTR to Exempt Health Care Goods from China Tariffs
FAH provided comments to the Department of Justice Antitrust Division (DOJ), Department of Health and Human Services (HHS), and Federal Trade Commission (FTC) regarding the Request for Information on Consolidation in Health Care Markets. FAH comments […]
Read More… from FAH Highlights the Value of Integrated Health Systems to Administration
Today, FAH sent comments to CMS on its proposed rule on Advancing Interoperability and Improving Prior Authorization Processes. FAH urges CMS to finalize patient protections in the rule, including shortening the health plan response times […]
Read More… from FAH Urges CMS to Implement Prior Authorization Improvements
Today the FAH submitted comments on CMS’s proposed rule on the CY 2023 hospital outpatient prospective payment system (OPPS). The FAH’s letter reinforced support of the current 340B drug payment policy following the June 2022 […]
Read More… from FAH Submits Comments on CY 2023 OPPS Proposed Rule
